Human monoclonal antibodies against TGF-beta II receptor and medicinal use thereof

Details for Australian Patent Application No. 2005200044 (hide)

Owner Japan Tobacco, Inc.

Inventors Kamata, Masafumi; Sakamoto, Shinji

Agent FB Rice

Pub. Number AU-A-2005200044

Parent 779871

Filing date 6 January 2005

Wipo publication date 3 February 2005

Acceptance publication date 7 June 2007

International Classifications

C12N 015/13 Mutation or genetic engineering - Immunoglobulins

A61P 043/00 Drugs for specific purposes, not provided for in groups

A61K 039/395 Medicinal preparations containing antigens or antibodies - Antibodies

C12N 005/16 Undifferentiated human, animal or plant cells, e.g. cell lines - Animal cells

C07K 016/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61P 029/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 019/02 Drugs for skeletal disorders

A61P 017/02 Drugs for dermatological disorders

A61P 017/04 Drugs for dermatological disorders

A61P 017/06 Drugs for dermatological disorders

A61P 009/10 Drugs for disorders of the cardiovascular system

A61P 009/08 Drugs for disorders of the cardiovascular system

A61P 001/16 Drugs for disorders of the alimentary tract or the digestive system

A61P 011/00 Drugs for disorders of the respiratory system

A61P 013/12 Drugs for disorders of the urinary system

Event Publications

20 January 2005 Complete Application Filed

3 February 2005 Application Open to Public Inspection

  Published as AU-A-2005200044

17 February 2005 Amendment Made

  The nature of the amendment is: Amend the name of the inventor from Kamata, Masafumi to Kamada, Masafumi.

7 June 2007 Application Accepted

  Published as AU-A-2005200044

4 October 2007 Standard Patent Sealed

10 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005200045-Use of 4-(2-fluorophenyl)-6-methyl-2-(1-pipera zinyl)thieno[2,3-D]pyrimidine for the treatment of pain

2005200043-Blasting method